Failure to Monitor for Adverse Effects of Antianxiety Medication
Penalty
No penalty information released
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Summary
The facility failed to monitor for adverse side effects in a resident who was prescribed an antianxiety medication, Lorazepam 0.5mg as needed for anxiety. The resident, who had multiple diagnoses including severe cognitive impairment due to dementia, was admitted to the facility and began receiving Lorazepam according to a physician's order. However, review of the electronic medication administration records for October and November showed that while the medication was administered, there was no documentation of monitoring for adverse side effects. Staff interviews confirmed that monitoring was expected but not performed, and the required order for monitoring was not placed until 32 days after the medication was initially ordered.